Sold Out
Book Categories |
Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; Role of novel mutations in MPN pathogenesis and outcome; Role of JAK inhibitors in MPN treatment; Animal Models of MPNs; and Role of Germline Genetic Factors in MPN Pathogenesis.
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionNon-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America
X
This Item is in Your InventoryNon-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America
X
You must be logged in to review the productsX
X
X
Add Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America, Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; , Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America to the inventory that you are selling on WonderClubX
X
Add Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America, Topics include: Clinical Predictors of Outcome in MPNs; Molecular pathogenesis of MPNs; Disordered signaling in MPNs; Role of TET2/ASXL1 in MPN Pathogenesis; Pathogenesis and treatment of systemic mastocytosis; Role of additional novel therapies in MPNs; , Non-CML Myeloproliferative Diseases, An Issue of Hematology/Oncology Clinics of North America to your collection on WonderClub |